Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.175 USD | -2.33% | -15.36% | +0.98% |
Jun. 01 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
May. 13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.98% | 2.34B | |
-40.81% | 8.27B | |
-0.83% | 3.35B | |
-19.81% | 2.02B | |
-22.72% | 1.62B | |
+32.52% | 1.16B | |
-7.21% | 713M | |
+17.17% | 696M | |
-36.43% | 488M | |
-6.86% | 274M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates